In Vivo

The Directed In Vivo Angiogenesis Assay (DIVAA™) has been developed for evaluating angiogenesis in vivo.  This line of products utilize PathClear® Basement Membrane Extract (BME), Trevigen’s Basement Membrane Matrix, and DIVAA™ angioreactors, which are small, implant grade silicone cylinders that are sealed on one end, to quantitatively and reproducibly measure in vivo angiogenesis. By encapsulating the angiogenic response, DIVAA™ preserves vascular integrity and prevents absorption of experimental sample, avoiding the pitfalls of the Matrigel Plug Assay.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
News